N4 Pharma Share Discussion Threads

[gkp heros] 08/3/2018 09:03

Get a viagra down you, it will soon start to go up!!!

[deltrotter] 08/3/2018 09:01

£1 today

[alia] 08/3/2018 08:58

evrh also guys moving up

[parob] 08/3/2018 08:29

Two top ups for me but that wasn't easy!

[urigem] 08/3/2018 08:29

only managed 11k shares at 25.2

[urigem] 08/3/2018 08:25

right I'm going in for some...

[alia] 08/3/2018 08:16

guys vast coming out with huge news tomorrow, get in before the rns

[waterloo01] 08/3/2018 08:16

This is quite an important speech from the head of FDA on biosimilars.

[ch1rp] 08/3/2018 08:08

Shrewd investors will wait till inpatient profiteers have left the building. Best share on AIM:)))

[dplewis1] 08/3/2018 08:07

He has a good CV but he hasn't moved from AZN to N4, check his LinkedIn - he worked at Astra 5 years ago

[jimbobaroony] 08/3/2018 08:06

A good update, but not company changing. Not yet.

[jakleeds] 08/3/2018 07:59

Great update and a cracking appointment

From John 0777 on LSE /
AZNs senior research scientist has made the move to a little minnow like us.... You don’t do that unless you see massive potential in the minnows technology.....

[parob] 08/3/2018 07:59

Whilst there are currently no approved products which use nanosilica as a drug delivery vehicle, the total market size for nanotechnology drug delivery was valued at $79 billion in 2012 and is expected to reach a value of $178 billion in 2019, representing a compound annual growth rate of 4.15% (further details below).

[bones] 08/3/2018 07:57

"....Whilst the Company awaits the imminent commencement of pilot human trials for its reformulation of sildenafil...."End of April results here are looking a tad optimistic.Before anyone cries foul, I am managing my own expectations here as I have a shed full of N4P :)As I said yesterday, it's unusual for these plans to run on time.I think Nigel T is also using this RNS to manage expectations on Nuvec as there are some here seem to think all the collaborations will happen immediately and that Nuvec's development is straightforward.It's so refreshing to see a clearly written and explained RNS being on the one hand realistic and on the other spelling out the potential for huge success.None of this covers all the other drug reformulations nor Nuvac (as opposed to Nuvec), which are in the background pipeline.

[ch1rp] 08/3/2018 07:57

Oh, and nuvec alone part of a £178 billion market:)))

[eddie_yates] 08/3/2018 07:56

I hope I'm wrong but I can see this falling on this news

[ch1rp] 08/3/2018 07:54

Wow! This is great news! Nigel is underlining the credentials and potential of N4P. More and more professional involvement, funding to secure deals, human trails of sikdenafil underway, deals for nuvec in the pipeline, Japan a success just WOW!!!!

[urigem] 08/3/2018 07:46

very quiet you lazy lot... seeing how this has held up so well on the dripping volume, i dont think there will exactly be a floor of sellers at these levels - therefore where will those shares come from? - only one way to go :)

[urigem] 08/3/2018 07:18

Nice update. More collaborations on the way, clear bussiness plan.

I really like NT professionalism, great appointment as well. just firms up our current beliefs that Nuvec will be huge

[deeppockets] 08/3/2018 07:13

All heading in the right direction. Seems to confirm no need for new funds.

[hughwilson] 07/3/2018 15:50

The touchpaper is there in the form of collaborations. Looking forward to first revenues to light it.

[jimbobaroony] 07/3/2018 15:45

Jak is an eternal optimist.

Bones, careful, statements like that will see you labelled as a deramper.

[bones] 07/3/2018 12:27

jakleeds, you said "Sildenafil results due any day now".

However, last July, we were updated with this comment:

"The Pilot Trial is due to take place in early 2018 with results expected by the end of April 2018."

Are you aware of an acceleration of the timetable? It's rare for these things to stay on track, never mind come forward :)